1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Muscle Injury Global Clinical Trials Review, H2, 2015

Muscle Injury Global Clinical Trials Review, H2, 2015

  • October 2015
  • -
  • GlobalData
  • -
  • 58 pages

Muscle Injury Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Muscle Injury Global Clinical Trials Review, H2, 2015" provides an overview of Muscle Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Muscle Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Muscle Injury Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Muscle Injury to Musculoskeletal Clinical Trials 13
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Muscle Injury to Musculoskeletal Clinical Trials 17
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Muscle Injury Therapeutics Clinical Trials 28
Prominent Drugs 30
Clinical Trial Profile Snapshots 31
Appendix 55
Abbreviations 55
Definitions 55
Research Methodology 56
Secondary Research 56
About GlobalData 57
Contact Us 57
Disclaimer 57
Source 58

List of Tables
Muscle Injury Therapeutics, Global, Clinical Trials by Region, 2015* 5
Muscle Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Muscle Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Muscle Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9
Muscle Injury Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10
Muscle Injury Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Muscle Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12
Proportion of Muscle Injury to Musculoskeletal Clinical Trials, G7 Countries (%), 2015* 14
Muscle Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Muscle Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Muscle Injury to Musculoskeletal Clinical Trials, E7 Countries (%), 2015* 18
Muscle Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Muscle Injury Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Muscle Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Muscle Injury Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Muscle Injury Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Muscle Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Muscle Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Muscle Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Muscle Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Muscle Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

List of Figures
Muscle Injury Therapeutics, Global, Clinical Trials by Region (%), 2015* 5
Muscle Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6
Muscle Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Muscle Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9
Muscle Injury Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10
Muscle Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 12
Proportion of Muscle Injury to Musculoskeletal Clinical Trials, G7 Countries (%), 2015* 13
Muscle Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Muscle Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Muscle Injury to Musculoskeletal Clinical Trials, E7 Countries (%), 2015* 17
Muscle Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Muscle Injury Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Muscle Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Muscle Injury Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Muscle Injury Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Muscle Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Muscle Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Muscle Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Muscle Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Muscle Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 56

Companies Mentioned
Pluristem Therapeutics Inc.
Regenerative Sciences, Inc.
GlaxoSmithKline Plc
Cytori Therapeutics, Inc.
Chengde Jingfukang Pharmaceutical Group
Biologische Heilmittel Heel GmbH
Atrium Innovations Inc.
Aspetar
Arthrex, Inc.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorde ...

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung ...

OpportunityAnalyzer: Myelofibrosis - Opportunity Analysis and Forecasts to 2025

OpportunityAnalyzer: Myelofibrosis - Opportunity Analysis and Forecasts to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

OpportunityAnalyzer: Myelofibrosis - Opportunity Analysis and Forecasts to 2025 Summary Myelofibrosis (MF) is a rare blood disorder, which is characterized by bone marrow fibrosis. Currently, there is ...


Download Unlimited Documents from Trusted Public Sources

Diabetes Statistics

  • February 2017
    10 pages
  • Diabetes  

    Therapy  

View report >

The future of the Health Facility Industry in the US

  • February 2017
    9 pages
  • Health Facility  

    Nursing Home  

  • United States  

View report >

Opioid Market in the US

  • February 2017
    4 pages
  • Opioid  

  • United States  

View report >

Related Market Segments :

Therapy

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.